Revealed: US Cell Viability Assays Market Share to Exceed $1.5 Billion by 2035
The US cell viability assays market is on track for unprecedented growth, projected to witness a market share exceeding $1.5 billion by 2035. The anticipated compound annual growth rate (CAGR) stands at 8.5%, reflecting a robust expansion driven by technological advancements and increased demand for drug development. The current market size is estimated at $625.84 million in 2024, showcasing...
0 Commentaires 0 Parts 2 Vue 0 Aperçu